R.F. & R.F. v. Abbott Laboratories

713 A.2d 497, 154 N.J. 606, 1998 N.J. LEXIS 1120
CourtSupreme Court of New Jersey
DecidedJuly 21, 1998
StatusPublished
Cited by2 cases

This text of 713 A.2d 497 (R.F. & R.F. v. Abbott Laboratories) is published on Counsel Stack Legal Research, covering Supreme Court of New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
R.F. & R.F. v. Abbott Laboratories, 713 A.2d 497, 154 N.J. 606, 1998 N.J. LEXIS 1120 (N.J. 1998).

Opinion

Petition for certification is granted, and the matter is summarily remanded to the Appellate Division for consideration of the non-preemption issues raised by plaintiffs in their appeal and for reconsideration of the preemption issue in the light of Baird v. American Medical Optics, 155 N.J. 54, 713 A.2d 1019 (1998), and the pertinent regulation of the FDA reported at 62 Fed.Reg. 65387 (1997) (to be codified at 21 C.F.R. pt. 808) (proposed December 12, 1997).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

R.F. v. Abbott Laboratories
745 A.2d 1174 (Supreme Court of New Jersey, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
713 A.2d 497, 154 N.J. 606, 1998 N.J. LEXIS 1120, Counsel Stack Legal Research, https://law.counselstack.com/opinion/rf-rf-v-abbott-laboratories-nj-1998.